DB
David S Barlow
10% Owner

David S Barlow insider trades: Molecular Insight Pharmaceuticals (MIPI) stock buys and sales

10% Owner, Molecular Insight Pharmaceuticals Last trade Jan 28, 2011 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2005
2
Companies
last trade 2011

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 28, 2011MIPI↓ Sell$16K
Dec 17, 2010MIPI↓ Sell$40K
Jan 14, 2010MIPI↓ Sell$20K
Dec 24, 2009MIPI↓ Sell$37K
Dec 21, 2009MIPI↓ Sell$27K
Nov 30, 2007MIPI↑ Buy$42K
Nov 20, 2007MIPI↑ Buy$102K
Jan 3, 2007NRPH↓ Sell$548K
Dec 1, 2006NRPH↓ Sell$490K
May 18, 2006NRPH↓ Sell$292K
Mar 20, 2006NRPH↓ Sell$309K
Nov 22, 2005NRPH↓ Sell$257K
Aug 19, 2005NRPH↓ Sell$185K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David S Barlow's insider trades

David S Barlow is a 10% owner of Molecular Insight Pharmaceuticals (MIPI). Since Aug 19, 2005, David has reported 2 open-market purchases worth $144K and 11 sales worth $2.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (9 filings), grants and awards (4 filings), conversions (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MIPI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.